Home Pharma

Digital Health Bites

In unserem Blog finden Sie Trends und Neuigkeiten rund um MedTech, EU-MDR, klinische Studien und Digital Health und bleiben Sie bei Änderungen regulatorischer Anforderungen immer auf dem aktuellsten Stand.

Category: Pharma

Sascha | Co-Founder & CEO for Climedo, June 07, 2022

How Can the Patient Journey in Oncology be Improved? 

The International Agency for Research on Cancer estimates the number of new cancer cases around 19.3 million worldwide for 2020. This number is expected to increase to around 30 million cases by 2040....

How Can the Patient Journey in Oncology be Improved? 
Arrow Right

Robert Joyce for Climedo, 25. May 2022

The 5 I’s of Patient Involvement: Planning for Success

Arrow Right
The 5 I’s of Patient Involvement: Planning for Success

Tereza | Senior Customer Success Manager for Climedo, 04. January 2022

3 Success Factors that Determine the Course of Phase IV Trials

Arrow Right
3 Success Factors that Determine the Course of Phase IV Trials

Dennie Rothbächer I Head of Business Development for Climedo, 15. December 2021

Leveraging diversity to make a difference in clinical trials

Arrow Right
Leveraging diversity to make a difference in clinical trials

Veronika | Co-Founder & COO for Climedo, 10. December 2021

Climedo Connect: The digital patient – Data protection in the healthcare sector

Arrow Right
Climedo Connect: The digital patient – Data protection in the healthcare sector

Tereza | Senior Customer Success Manager for Climedo, 24. November 2021

5 Advantages of eCRFs in Clinical Trials

Arrow Right
5 Advantages of eCRFs in Clinical Trials

Catherine | Marketing Lead for Climedo, 02. November 2021

Climedo Connect: Decentralized and connected – The future of clinical trials

Arrow Right
Climedo Connect: Decentralized and connected – The future of clinical trials
Mehr laden

CLIMEDO IN THE NEWS

A guest article by Veronika Schweighart in Tagesspiegel Background (in German) Climedo is sponsoring ACDM's DCT Symposium in Amsterdam this June Climedo's blog among the Top 80 European Healthcare Blogs People behind healthcare innovation: McKinsey Interview Climedo publishes new ePRO expert guide Climedo wins 2nd place for the Deloitte Fast 50 Award Climedo is among the "Health Tech Challengers" finalists Business Model Configurations in Digital Healthcare – a German Case Study about Digital Transformation Majority of diagnostic companies still implementing IVDR as deadline nears German healthtech startup Climedo picks up €5 million funding boost Outsourcing-Pharma: Survey: research industry keen on DCT benefits, slow to adopt Outsourcing-Pharma: Survey seeks to chart adoption of decentralized trials, future plans RAPS: Challenges and opportunities in medical device clinical trials in Europe CenterWatch: European Trials Lag Behind U.S. in Decentralization, Survey Finds Outsourcing-Pharma: Report reveals obstacles to implementing digital trial tech Healthcare Global: A guide to labelling compliance for medical devices Easy Medical Device: EU MDR Survey: What is the Industry’s opinion? RAPS: EU MDR Countdown: Readiness of medtech companies in Europe EPR: How small medical device manufacturers can achieve cost-effective compliant labelling MedTech Dive: EU MDR delay has not made new rules easier to stomach: exec poll RAPS: EU MDR survey: Time investment, costs, and personnel resources Easy Medical Device: What is the cost of an EU MDR project? Podcast: What is the true cost of the EU MDR? MedTech Insight: EU MDR Compliance Will Cost More Than 5% Of Revenues For Half Of Medtechs, Survey Says MedTechDive: EU MDR costing smaller medtechs 5% of their annual sales: survey Zollhof: Climedo’s digital symptom diary supported by Germany’s Federal Ministry of Health Helping MedTech companies comply with EU MDR: A case study Climedo Named Winner of EIT Health’s Headstart Program Medical Plastics News: How Covid-19 is impacting the medtech industry Survey results suggest medtech companies are not ready for EU MDR EIT Health: COVID-19 – Response from EIT Health Germany community